Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP878784.RAkSpakRwkrWyBrrd5QSnJtaNZSfRO6RZrkdUgqvZvotA130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878784.RAkSpakRwkrWyBrrd5QSnJtaNZSfRO6RZrkdUgqvZvotA130_provenance.
• NP826605.RAcPnm7ZRKx_aaef4hJ4_D67eCuE15SdHUpExdC3CquXQ130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826605.RAcPnm7ZRKx_aaef4hJ4_D67eCuE15SdHUpExdC3CquXQ130_provenance.
• NP884367.RAtaVcxm1DjJji8iUKU3P5KGDaCAulK4J9HsrpMRpEzQc130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP884367.RAtaVcxm1DjJji8iUKU3P5KGDaCAulK4J9HsrpMRpEzQc130_provenance.
• NP402601.RABCScZsaXN8uBgcoj_IDeRoNmcgIWG9bn3dvnbjjIUUY130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402601.RABCScZsaXN8uBgcoj_IDeRoNmcgIWG9bn3dvnbjjIUUY130_provenance.
• NP354927.RAhKgXc6XQIyRZuYIzccGWajE3RM3wop3bjdJGABERyC4130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354927.RAhKgXc6XQIyRZuYIzccGWajE3RM3wop3bjdJGABERyC4130_provenance.
• NP241125.RAoiPowcO9WjSd4my_lyalHLgWT3x706vFLYWHTN1kzmo130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241125.RAoiPowcO9WjSd4my_lyalHLgWT3x706vFLYWHTN1kzmo130_provenance.
• NP725600.RAt58IrX3D5mZNxHqO0u1zCFrm3qZbWELG5jhOVF5dzQY130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725600.RAt58IrX3D5mZNxHqO0u1zCFrm3qZbWELG5jhOVF5dzQY130_provenance.
• NP350636.RAeWnHJvQVmmgbVcTH1AAMQNISLKd06rKR9BHcv1DeKj8130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350636.RAeWnHJvQVmmgbVcTH1AAMQNISLKd06rKR9BHcv1DeKj8130_provenance.
• NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160679.RAH1oxQJ4wWRVHtZGaxD-CRhkNnqFdV4AHKjys2OdoXyo130_provenance.
• NP382577.RAy7TwFVB1t_aleg_7rVQ_MkSbpNuVpJ07rFoqvAbErnU130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382577.RAy7TwFVB1t_aleg_7rVQ_MkSbpNuVpJ07rFoqvAbErnU130_provenance.
• NP579234.RA_dUp7-mxGKUCe5pTiDSp5YN2jmEyTQJiEIElu_R7djM130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579234.RA_dUp7-mxGKUCe5pTiDSp5YN2jmEyTQJiEIElu_R7djM130_provenance.
• NP718989.RA-6wxca1ZtR4qup53vOLLkb41EUjwtfd0xltz1UBdOtw130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718989.RA-6wxca1ZtR4qup53vOLLkb41EUjwtfd0xltz1UBdOtw130_provenance.
• NP758482.RAFp_-7XGbJCx3q3iRb1h-fI77hPaCDgIAENfmGSRZs4M130_assertion description "[Adoptive transfer of chimeric antigen receptor (CAR)-expressing T cells is a promising new therapy for hematologic malignancies, but an ideal target antigen for CAR-expressing T-cell therapies for multiple myeloma has not been identified.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758482.RAFp_-7XGbJCx3q3iRb1h-fI77hPaCDgIAENfmGSRZs4M130_provenance.